Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
NKGen Biotech, Inc. issued 10,000,000 shares of the Company’s common stock of common stock to Asia Advisors Limited for at a purchase price of $0.25 per share, for an aggregate purchase price of $2,500,000.00.
- Security
- common stock
- Shares
- 10,000,000 shares of the Company’s common stock
- Purchaser
- Asia Advisors Limited
- Consideration
- at a purchase price of $0.25 per share, for an aggregate purchase price of $2,500,000.00
Exact text from the filing
On September 18, 2025, NKGen Biotech, Inc. (the “ Company ”) entered into a Stock Purchase Agreement (the “ SPA ”) with Asia Advisors Limited (the “ Purchaser ”), pursuant to which the Company agreed to issue and sell, and the Purchaser agreed to purchase, an aggregate of 10,000,000 shares of the Company’s common stock, par value $0.0001 per share (the “ Shares ”), at a purchase price of $0.25 per share (the “ Share Price ”), for an aggregate purchase price of $2,500,000.00.
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
NKGen Biotech, Inc. issued to purchase up to 20,000,000 shares of common stock of warrant to Asia Advisors Limited for exercisable at the Share Price.
- Security
- warrant
- Shares
- to purchase up to 20,000,000 shares of common stock
- Purchaser
- Asia Advisors Limited
- Consideration
- exercisable at the Share Price
Exact text from the filing
In addition to the Shares, the Company issued to the Purchaser a common stock purchase warrant (the “ Warrant ”) to purchase up to 20,000,000 shares of common stock, exercisable at the Share Price.
View on SEC.gov